Successful treatment of severe primary mitral regurgitation due to rheumatic aetiology using a novel‐designed transcatheter edge‐to‐edge repair system

The transcatheter edge‐to‐edge mitral valve repair (TEER) has been recommended as a reliable treatment option for selected patients with severe degenerative and functional mitral regurgitation (MR). Although MR patients with rheumatic etiology were excluded from two significant trials (EVEREST II an...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2024-06, Vol.103 (7), p.1148-1151
Main Authors: Xie, Chun‐Mei, Zhu, Da, Wang, Shou‐Zheng, Pan, Xiang‐Bin
Format: Article
Language:English
Subjects:
case report
Clinical trials
Etiology
mitral regurgitation
Mitral valve
Regurgitation
rheumatic heart disease
transcatheter edge‐to‐edge mitral valve repair
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The transcatheter edge‐to‐edge mitral valve repair (TEER) has been recommended as a reliable treatment option for selected patients with severe degenerative and functional mitral regurgitation (MR). Although MR patients with rheumatic etiology were excluded from two significant trials (EVEREST II and COAPT) that established a role for the TEER in degenerative and functional MR. However, it has been reported that the TEER procedure could be safely and effectively performed in carefully selected rheumatic MR patients. Therefore, we share a case report of successfully treating severe rheumatic MR using a novel‐designed TEER system (JensClipTM).
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.31058